To investigate whether persistent enhancement detected on contrast‐enhanced sonography at postoperative day 1 (early contrast‐enhanced sonography) after cryoablation of renal tumors implies the presence of residual viable tumor tissue, defined… Click to show full abstract
To investigate whether persistent enhancement detected on contrast‐enhanced sonography at postoperative day 1 (early contrast‐enhanced sonography) after cryoablation of renal tumors implies the presence of residual viable tumor tissue, defined as residual enhancing tissue on reference imaging (computed tomography or magnetic resonance imaging) performed 6 months after the procedure.
               
Click one of the above tabs to view related content.